Literature DB >> 26854237

Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair.

Tony Gutschner1, Monika Haemmerle2, Giannicola Genovese3, Giulio F Draetta4, Lynda Chin5.   

Abstract

CRISPR/Cas9 induces DNA double-strand breaks that are repaired by cell-autonomous repair pathways, namely, non-homologous end-joining (NHEJ), or homology-directed repair (HDR). While HDR is absent in G1, NHEJ is active throughout the cell cycle and, thus, is largely favored over HDR. We devised a strategy to increase HDR by directly synchronizing the expression of Cas9 with cell-cycle progression. Fusion of Cas9 to the N-terminal region of human Geminin converted this gene-editing protein into a substrate for the E3 ubiquitin ligase complex APC/Cdh1, resulting in a cell-cycle-tailored expression with low levels in G1 but high expression in S/G2/M. Importantly, Cas9-hGem(1/110) increased the rate of HDR by up to 87% compared to wild-type Cas9. Future developments may enable high-resolution expression of genome engineering proteins, which might increase HDR rates further, and may contribute to a better understanding of DNA repair pathways due to spatiotemporal control of DNA damage induction.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; MALAT1; cell cycle; genome editing; homologous recombination; proteolysis; synthetic biology

Mesh:

Substances:

Year:  2016        PMID: 26854237     DOI: 10.1016/j.celrep.2016.01.019

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  96 in total

Review 1.  The present and future of genome editing in cancer research.

Authors:  Xiaoyi Li; Raymond Wu; Andrea Ventura
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

2.  Efficient generation of targeted large insertions by microinjection into two-cell-stage mouse embryos.

Authors:  Bin Gu; Eszter Posfai; Janet Rossant
Journal:  Nat Biotechnol       Date:  2018-06-11       Impact factor: 54.908

3.  Marker-free coselection for CRISPR-driven genome editing in human cells.

Authors:  Daniel Agudelo; Alexis Duringer; Lusiné Bozoyan; Caroline C Huard; Sophie Carter; Jeremy Loehr; Dafni Synodinou; Mathieu Drouin; Jayme Salsman; Graham Dellaire; Josée Laganière; Yannick Doyon
Journal:  Nat Methods       Date:  2017-04-17       Impact factor: 28.547

Review 4.  Control of gene editing by manipulation of DNA repair mechanisms.

Authors:  Eric Danner; Sanum Bashir; Saniye Yumlu; Wolfgang Wurst; Benedikt Wefers; Ralf Kühn
Journal:  Mamm Genome       Date:  2017-04-03       Impact factor: 2.957

Review 5.  Ways of improving precise knock-in by genome-editing technologies.

Authors:  Svetlana A Smirnikhina; Arina A Anuchina; Alexander V Lavrov
Journal:  Hum Genet       Date:  2018-11-02       Impact factor: 4.132

Review 6.  Functional variomics and network perturbation: connecting genotype to phenotype in cancer.

Authors:  Song Yi; Shengda Lin; Yongsheng Li; Wei Zhao; Gordon B Mills; Nidhi Sahni
Journal:  Nat Rev Genet       Date:  2017-03-27       Impact factor: 53.242

7.  Genome engineering - Matching supply with demand.

Authors:  Tony Gutschner; Lynda Chin
Journal:  Cell Cycle       Date:  2016-04-06       Impact factor: 4.534

Review 8.  Clustered Regularly Interspaced Short Palindromic Repeats: Challenges in Treating Retinal Disease.

Authors:  Micah A Chrenek; John M Nickerson; Jeffrey H Boatright
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2016 Jul-Aug

9.  Recent evolution of a TET-controlled and DPPA3/STELLA-driven pathway of passive DNA demethylation in mammals.

Authors:  Christopher B Mulholland; Atsuya Nishiyama; Joel Ryan; Ryohei Nakamura; Merve Yiğit; Ivo M Glück; Carina Trummer; Weihua Qin; Michael D Bartoschek; Franziska R Traube; Edris Parsa; Enes Ugur; Miha Modic; Aishwarya Acharya; Paul Stolz; Christoph Ziegenhain; Michael Wierer; Wolfgang Enard; Thomas Carell; Don C Lamb; Hiroyuki Takeda; Makoto Nakanishi; Sebastian Bultmann; Heinrich Leonhardt
Journal:  Nat Commun       Date:  2020-11-24       Impact factor: 14.919

10.  Decoding non-random mutational signatures at Cas9 targeted sites.

Authors:  Amir Taheri-Ghahfarokhi; Benjamin J M Taylor; Roberto Nitsch; Anders Lundin; Anna-Lina Cavallo; Katja Madeyski-Bengtson; Fredrik Karlsson; Maryam Clausen; Ryan Hicks; Lorenz M Mayr; Mohammad Bohlooly-Y; Marcello Maresca
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.